INDP
Indaptus Therapeutics, Inc.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
7
Buys
6
Sells
1
Largest Trade
$100K–$500K
Insiders
5
Institutional Funds
2
Inst. Value
$50K–$100K
Activist Filings
9
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Anderson Glen R. | 10% Owner | BUY | $100K–$500K | 103K | $2.09 | Aug 16, 2023 |
| Litchev Boyan Vesselinov | Chief Medical Offi… | BUY | $1K–$15K | 1K | $2.19 | Dec 20, 2022 |
| Meckler Jeffrey A | CEO and Director | BUY | $15K–$50K | 10K | $1.89 | Nov 22, 2022 |
| Meckler Jeffrey A | CEO and Director | BUY | $15K–$50K | 10K | $2.80 | Sep 12, 2022 |
| Linscott Walt Addison | Chief Business Off… | BUY | <$1K | 150 | $2.62 | Sep 9, 2022 |
| Meckler Jeffrey A | CEO and Director | BUY | $15K–$50K | 10K | $2.56 | Sep 8, 2022 |
| Newman Michael James | CSO and Director | SELL | $100K–$500K | 20K | $5.00 | Feb 2, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| UBS Group AG | 29K | $50K–$100K | SH |
| SBI Securities Co., Ltd. | 17 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D · Mar 2, 2026
98.0%
111.0M shares
SC 13D/A · Dec 30, 2025
12.7%
273K shares
SC 13D/A · Dec 30, 2025
5.4%
116K shares
SC 13G · Feb 18, 2025
10.0%
1.4M shares
SC 13D/A · Nov 26, 2024
6.9%
876K shares
SC 13D · Oct 10, 2024
7.3%
791K shares
SC 13G/A · Aug 16, 2023
14.2%
1.2M shares
SC 13G/A · Jul 7, 2022
13.2%
1.1M shares
SC 13G/A · Feb 11, 2022
0.7%
60K shares